These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31659743)

  • 1. Plasma levels of the cardiovascular protective endogenous nucleoside adenosine are reduced in patients with primary aldosteronism without affecting ischaemia-reperfusion injury: A prospective case-control study.
    van den Berg TNAD; Thijssen DHJ; van Mil ACCM; van den Broek PH; Rongen GA; Monajemi H; Deinum J; Riksen NP
    Eur J Clin Invest; 2019 Dec; 49(12):e13180. PubMed ID: 31659743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of aldosterone-producing adenoma on endothelial function and Rho-associated kinase activity in patients with primary aldosteronism.
    Matsumoto T; Oki K; Kajikawa M; Nakashima A; Maruhashi T; Iwamoto Y; Iwamoto A; Oda N; Hidaka T; Kihara Y; Kohno N; Chayama K; Goto C; Aibara Y; Noma K; Liao JK; Higashi Y
    Hypertension; 2015 Apr; 65(4):841-8. PubMed ID: 25624340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart failure is associated with exaggerated endothelial ischaemia-reperfusion injury and attenuated effect of ischaemic preconditioning.
    Seeger JP; Benda NM; Riksen NP; van Dijk AP; Bellersen L; Hopman MT; Cable NT; Thijssen DH
    Eur J Prev Cardiol; 2016 Jan; 23(1):33-40. PubMed ID: 25389072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism.
    Nishizaka MK; Zaman MA; Green SA; Renfroe KY; Calhoun DA
    Circulation; 2004 Jun; 109(23):2857-61. PubMed ID: 15173035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microvascular endothelial function is impaired in patients with idiopathic hyperaldosteronism.
    Kishimoto S; Matsumoto T; Oki K; Maruhashi T; Kajikawa M; Matsui S; Hashimoto H; Kihara Y; Yusoff FM; Higashi Y
    Hypertens Res; 2018 Nov; 41(11):932-938. PubMed ID: 30206323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma osteopontin levels are higher in patients with primary aldosteronism than in patients with essential hypertension.
    Irita J; Okura T; Manabe S; Kurata M; Miyoshi K; Watanabe S; Fukuoka T; Higaki J
    Am J Hypertens; 2006 Mar; 19(3):293-7. PubMed ID: 16500516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherosclerotic Burden and Arterial Stiffness are Not Increased in Patients with Milder Forms of Primary Aldosteronism Compared to Patients with Essential Hypertension.
    Lottspeich C; Köhler A; Czihal M; Heinrich DA; Schneider H; Handgriff L; Reincke M; Adolf C
    Horm Metab Res; 2021 Mar; 53(3):178-184. PubMed ID: 33440431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Montmorency cherry supplementation attenuates vascular dysfunction induced by prolonged forearm occlusion in overweight, middle-aged men.
    Aboo Bakkar Z; Fulford J; Gates PE; Jackman SR; Jones AM; Bond B; Bowtell JL
    J Appl Physiol (1985); 2019 Jan; 126(1):246-254. PubMed ID: 30496705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldosterone induces left ventricular subclinical systolic dysfunction: a strain imaging study.
    Chen ZW; Huang KC; Lee JK; Lin LC; Chen CW; Chang YY; Liao CW; Wu VC; Hung CS; Lin YH;
    J Hypertens; 2018 Feb; 36(2):353-360. PubMed ID: 28902663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of biomarkers of endothelial dysfunction and microvascular endothelial function in patients with primary aldosteronism and essential hypertension.
    Sang M; Fu Y; Wei C; Yang J; Qiu X; Ma J; Qin C; Wu F; Zhou X; Yang T; Sun M
    J Renin Angiotensin Aldosterone Syst; 2021; 22(1):1470320321999491. PubMed ID: 33678006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations Between Metabolic Profiles and Target-Organ Damage in Chinese Individuals With Primary Aldosteronism.
    Zhang SL; Gao JW; Guo Y; Feng QL; Tang JY; Yan L; Wang JF; Cheng H; Liu PM
    Front Endocrinol (Lausanne); 2020; 11():547356. PubMed ID: 33101195
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal impairment is closely associated with plasma aldosterone concentration in patients with primary aldosteronism.
    Kawashima A; Sone M; Inagaki N; Takeda Y; Itoh H; Kurihara I; Umakoshi H; Ichijo T; Katabami T; Wada N; Ogawa Y; Kawashima J; Fujita M; Miyauchi S; Okamura S; Fukuoka T; Yanase T; Izawa S; Yoshikawa Y; Hashimoto S; Yamada M; Kai T; Suzuki T; Naruse M
    Eur J Endocrinol; 2019 Sep; 181(3):339-350. PubMed ID: 31319380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperaldosteronism and cardiovascular risk in patients with autosomal dominant polycystic kidney disease.
    Lai S; Petramala L; Mastroluca D; Petraglia E; Di Gaeta A; Indino E; Panebianco V; Ciccariello M; Shahabadi HH; Galani A; Letizia C; D'Angelo AR
    Medicine (Baltimore); 2016 Jul; 95(29):e4175. PubMed ID: 27442639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postconditioning protects against human endothelial ischaemia-reperfusion injury via subtype-specific KATP channel activation and is mimicked by inhibition of the mitochondrial permeability transition pore.
    Okorie MI; Bhavsar DD; Ridout D; Charakida M; Deanfield JE; Loukogeorgakis SP; MacAllister RJ
    Eur Heart J; 2011 May; 32(10):1266-74. PubMed ID: 21362704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of inhibition of aldosterone secretion by a Ca2+ channel blocker in patients with essential hypertension and patients with primary aldosteronism].
    Yokoyama T; Shimamoto K; Iimura O
    Nihon Naibunpi Gakkai Zasshi; 1995 Nov; 71(7):1059-74. PubMed ID: 8582487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marinobufagenin in essential hypertension and primary aldosteronism: a cardiotonic steroid with clinical and diagnostic implications.
    Tomaschitz A; Piecha G; Ritz E; Meinitzer A; Haas J; Pieske B; Wiecek A; Rus-Machan J; Toplak H; März W; Verheyen N; Gaksch M; Amrein K; Kraigher-Krainer E; Fahrleitner-Pammer A; Pilz S
    Clin Exp Hypertens; 2015; 37(2):108-15. PubMed ID: 24785704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and Gene Expression Analysis of Serum-Derived Extracellular Vesicles in Primary Aldosteronism.
    Burrello J; Gai C; Tetti M; Lopatina T; Deregibus MC; Veglio F; Mulatero P; Camussi G; Monticone S
    Hypertension; 2019 Aug; 74(2):359-367. PubMed ID: 31230554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of black tea consumption on brachial artery flow-mediated dilation and ischaemia-reperfusion in humans.
    Schreuder TH; Eijsvogels TM; Greyling A; Draijer R; Hopman MT; Thijssen DH
    Appl Physiol Nutr Metab; 2014 Feb; 39(2):145-51. PubMed ID: 24476469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldosterone Impairs Vascular Smooth Muscle Function: From Clinical to Bench Research.
    Chou CH; Chen YH; Hung CS; Chang YY; Tzeng YL; Wu XM; Wu VC; Tsai CT; Wu CK; Ho YL; Wu KD; Lin YH;
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4339-47. PubMed ID: 26401591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of metformin on endothelial ischemia-reperfusion injury in humans in vivo: a prospective randomized open, blinded-endpoint study.
    El Messaoudi S; Schreuder TH; Kengen RD; Rongen GA; van den Broek PH; Thijssen DH; Riksen NP
    PLoS One; 2014; 9(4):e96062. PubMed ID: 24755906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.